We welcome our guest, Madeline King, PharmD, BCIDP

Assistant Professor of Clinical Pharmacy, Infectious Diseases,

Department of Pharmacy Practice & Pharmacy Administration.

Dr. King joins us to discuss the updated Clostridioides difficile (C. difficile) Guidelines,

along with topic of Antibiotics. Dr. King has a passion

in infectious disease, public health, and truly enjoys teaching.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.

Episode 6

Group Discussion I ‘Recent Developments in Diagnosis, Treatment, and Prevention of

C. difficile infections In Children.’

GROUP DISCUSSION I Thursday Afternoon

Speakers

Thomas J. Sandora, MD MPH (Speaker) Associate Professor of Pediatrics : PANELIST, Harvard Medical School : Panel Discussion I

Larry Kociolek, MD (Speaker) Attending Physician, Ann & Robert H. Lurie Children’s Hospital

Maribeth Nicholson, MD, MPH (Speaker) Assistant Professor of Pediatrics, Vanderbilt University Medical Center.

---

'Introduction to Microbiota and Microbiota Restoration for Recurrent C diff infections'

Ken Blount, Ph.D. (Speaker) Chief Scientific Officer, Rebiotix, Inc a Ferring Company

----

We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.

Episode 5

A Caregiver's Journey

David Bischoff (Speaker) Co-Coordinator VHA Program, C Diff Foundation

A Caregiver's Perspective ~ Caring For a Loved One Diagnosed With a CDI

---

“Is this C.diff.? How IBS and IBD Complicate the Diagnosis and Management of Patients With a CDI”

Caterina Oneto, MD (Speaker) Clinical Instructor, Division of Gastroenterology, NYU

---

“The Burden of Clostridioides difficile Infection In the COVID-19 Era”

Nicola Petrosillo (Speaker) Head Infection Control and Infectious Disease Service, University Hospital Campus Bio-Medico, Rome, Italy

---

We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.

Episode 4

---

'Using a Gut Model to Predict Which Antibiotics Are Associated with CDI and Which Ones Best Treat CDI'

Mark Wilcox, MD, FRCPath (Speaker) Consultant Microbiologist, Head of Microbiology and Academic Lead of Pathology, Leeds Teaching Hospitals

---

Microbiome Therapeutics in 2021: Almost there for C difficile!

Sahil Khanna, MBBS MS (Speaker) Professor of Medicine in the Division of Gastroenterology and Hepatology,, Mayo Clinic

---

We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l

C. diff. Conference & Health EXPO.

This is a wonderful opportunity to listen and learn from world-renown topic leaders from the 9th Annual International C. diff. Conference & Health EXPO November 4-5, 2021.

Episode 3

Update on the Development of Gut Microbiome Protectors from Antibiotic-Induced Dysbiosis.

Florence Sejourne (Speaker) CEO, DA VOLTERRA

---

“Safety and Efficacy of Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent Clostridioides difficile Infection: A Data Summary From Five Prospective Studies”

Beth Guthmueller (Speaker) Rebiotix, a Ferring Company

---

‘CP101, an Investigational Orally Administered Microbiome Therapeutic Designed to Prevent Recurrent CDI’

Shrish Budree (Speaker) Medical Director, Head of Clinical Microbiome Science, Finch Therapeutics

---

We thank ACURX Pharmaceuticals for being the Audio Sponsor of the 9th Annual Int'l C. diff. Conference & Health EXPO.

This is a wonderful opportunity to listen and learn from world-renown

topic leaders from the 9th Annual International C. diff. Conference & Health EXPO

November 4-5, 2021.

Episode 2

“The Burden of Clostridioides difficile Infection In the COVID-19 Era”

Nicola Petrosillo (Speaker) Head Infection Control and Infectious Disease Service, University Hospital Campus Bio-Medico, Rome, Italy

**

Results from ECOSPOR III, a Phase 3 Placebo-Controlled Trial of SER-109, an Investigational Microbiome Therapeutic to Reduce Recurrence of Clostridioides difficile Infection

Barbara McGovern, MD (Speaker) VP, Medical Affairs, Seres Therapeutics

**

Evidence-Based Hand Hygiene In the Post-COVID World.”

Tamas Haidegger (Speaker) Associate Professor, Óbuda University

**

We thank ACURX Pharmaceuticals for being the Audio Sponsor of the

9th Annual Int'l C. diff. Conference & Health EXPO.

This is a wonderful opportunity to listen and learn from world-renown

topic leaders from the 9th Annual International C. diff. Conference & Health EXPO

November 4-5, 2021.

Episode 1

Paul Feuerstadt, MD, FACG, AGAF introduce the C Diff Foundation and provide an overview of a C. difficile infection.

Simon M. Cutting, Ph.D. will present: What Makes Us Susceptible to a C. difficile Infection?

We thank ACURX Pharmaceuticals for being the Audio Sponsor of the

9th Annual Int'l C. diff. Conference & Health EXPO.

Join us with our guest; Ken Blount PhD, CSO Rebiotix Inc, a Ferring Company and VP Microbiome Research Ferring - as Dr. Blount introduces the gut microbiome. There is so much to learn about this cutting edge science, along with a discussion about the recurrence of a C. difficile infection , and how clinical trials work.. The gut microbiome has a direct connection to our health and Dr. Blount will be shining some light on this educational topic

Have your mobile devices or a pen and notebook ready as we learn more about the gut microbiome, C. difficile infections, clinical trials, and much more!

Nancy C. Caralla and Kevin Hersh as we discuss the chapters and passion behind the newly published book, Managing a C. difficile Infection: For Patients, Families, and Caregivers.

Join Us With our guest, Sahil Khanna, M.B.B.S., M.S. as we discuss the exciting times

of Microbiome Restoration For C. difficile infections and how we are almost

there! Dr. Khanna will be introducing the gut microbiome, the research, development, and importance of the microbiome in our health along with the microbiome therapeutics in clinical trials with validated safety and efficacy.